Kai Hu
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 4
- Cancer-related gene regulation 4
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 7
- Co-authors
- Rensheng Wang (22 shared papers)Fang Wu (6 shared papers)Yong Zhang (6 shared papers)Meilian Liu (4 shared papers)Jinxian Zhu (4 shared papers)Guisheng Li (3 shared papers)Haolin Yan (4 shared papers)Guosheng Feng (2 shared papers)
- Journals
- Frontiers in Oncology (3 papers)FEBS Open Bio (2 papers)Dose-Response (2 papers)Biosensors and Bioelectronics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Kai Hu
50 papers receiving 787 citations
Peers
Comparison fields: 5 of 82
- Otorhinolaryngology 185
- Cancer Research 244
- Reproductive Medicine 62
- Oncology 196
- Pulmonary and Respiratory Medicine 197
Countries citing papers authored by Kai Hu
This map shows the geographic impact of Kai Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hu more than expected).
Fields of papers citing papers by Kai Hu
This network shows the impact of papers produced by Kai Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hu. The network helps show where Kai Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 110 | |
| 2 | 2022 | 72 | |
| 3 | 2012 | 45 | |
| 4 | 2021 | 43 | |
| 5 | 2016 | 35 | |
| 6 | 2015 | 35 | |
| 7 | Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial. | 2016 | 29 |
| 8 | 2009 | 28 | |
| 9 | 2022 | 27 | |
| 10 | 2018 | 24 | |
| 11 | 2019 | 23 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 21 | |
| 14 | 2024 | 21 | |
| 15 | 2009 | 21 | |
| 16 | 2021 | 19 | |
| 17 | 2022 | 17 | |
| 18 | 2020 | 16 | |
| 19 | 2022 | 16 | |
| 20 | 2021 | 15 |
About Kai Hu
Kai Hu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 53 papers that have together received 794 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Head and Neck Cancer Studies (9 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (6 papers), Effects of Radiation Exposure (5 papers), Cancer Cells and Metastasis (4 papers), Circular RNAs in diseases (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Otorhinolaryngology (185 citations), Cancer Research (244 citations), Reproductive Medicine (62 citations), Oncology (196 citations) and Pulmonary and Respiratory Medicine (197 citations). Kai Hu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rensheng Wang, Fang Wu, Yong Zhang, Meilian Liu, Jinxian Zhu, Guisheng Li, Haolin Yan, Guosheng Feng, Weimei Huang and Zhixun Li. Their work appears in journals such as Frontiers in Oncology, FEBS Open Bio, Dose-Response, Biosensors and Bioelectronics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.